Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $22.29 -2.15%
Rating Summary:
10 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
10 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
Barclays analyst Glen Santangelo lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $48.00 (from $56.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
- Alamtri Minerals Indonesia (ADMR:IJ) PT Lowered to IDR2,230 at JPMorgan
- Weatherford International plc (WFRD) PT Lowered to $116 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
